Ophthalmology

Long-term ranibizumab beneficial for macular edema

(HealthDay)—Long-term aggressive treatment of patients with macular edema with ranibizumab during a third year correlates with reduced mean foveal thickness (FTH) and improved best-corrected visual acuity (BCVA), according ...

Oncology & Cancer

Drug can delay ovarian cancer relapses: study

A drug already approved for treating kidney cancer was successful at delaying the return of advanced ovarian cancer by an average of nearly six months, a clinical study released Saturday found.

Cardiology

Why do women get statins less frequently than men?

Women are less likely than men to be treated with cholesterol-lowering statins—or get them prescribed at guideline-recommended intensity levels when they do, according to a new study that also looked at reasons behind the ...

Health

Dying elderly need comforting, not rescuing, according to study

UNSW medical researchers are calling for restraint on the use of aggressive life-saving treatments for frail elderly patients at the end of their lives, saying the focus should instead be placed on making patients' last days ...

Oncology & Cancer

COUP-TFII sparks prostate cancer progression

Prostate cancer presents a dilemma for patients and the physicians who treat them. Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and which need aggressive ...

page 8 from 18